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Abstract
The objective of this study was to describe the pregnancy intentions of pregnant HIV-infected 
Malawian women on antiretroviral therapy (ART) for at least 6 months prior to the current 
pregnancy, and to assess whether time on ART was associated with pregnancy intention. We 
conducted a cross-sectional analysis of HIV-infected Malawian women receiving antenatal care at 
a government hospital with a survey assessing ART history, reproductive history, and family 
planning use at conception. We used Pearson’s chi-square tests and Fisher’s exact tests to compare 
these parameters between women on ART greater than 24 months with those on ART less than 24 
months. Modified Poisson regression was performed to assess the association between time on 
ART and pregnancy intention. Most women (75%) reported that their current pregnancy was 
unintended, defined as either mistimed (21%) or unwanted (79%). Women on ART for longer than 
2 years were more likely to report an unintended pregnancy (79% versus 65%, p=0.03), though 
there was no significant association between time on ART and pregnancy intention in multivariate 
analysis. Most women (79%) were using contraception at the time of conception, with condoms 
being most popular (91%), followed by injectables (9%) and the implant (9%). HIV-infected 
women on ART continue to experience high rates of unintended pregnancy in the Option B+ era. 
As Option B+ continues to be implemented in Malawi and increasing numbers of HIV-infected 
women initiate lifelong ART, ensuring that the most effective forms of contraception are 
accessible is necessary to decrease unintended pregnancy.
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 Introduction
HIV and maternal mortality account for a significant proportion of morbidity and mortality 
among women worldwide (Hogan et al., 2010). Malawi is disproportionately affected by 
both, with an HIV prevalence rate of 11% and a maternal mortality rate of 460 deaths per 
100,000 (WHO, 2014). In July 2011, the country initiated a four-pronged strategy for HIV 
management, including prevention of unintended pregnancies among HIV-infected women 
via provider-initiated family planning of depot medroxyprogesterone (DMPA) injections and 
initiation of lifelong antiretroviral therapy (ART) for all HIV-infected pregnant and 
breastfeeding women, regardless of CD4+ count or WHO clinical stage, under the Option B
+ policy (Malawi Ministry of Health, 2011). The result was a substantial initial increase of 
748% in the number of women on ART between the second quarter of 2011 preceding 
Option B+ and third quarter of 2012 (Centers for Disease Control & Prevention, 2013). By 
the second quarter of 2013, 73% of pregnant HIV-infected women were on ART (Malawi 
Ministry of Health, 2013).
Malawi also has high rates of unintended pregnancy, especially among HIV-infected women. 
Not surprisingly, Malawi also has a high unmet need for contraception (National Statistical 
Office, 2011). While the 2010 Malawian Demographic Health Survey reported that 41% of 
pregnancies in Malawi are unintended (National Statistical Office, 2011), a 2011 survey of 
HIV-infected women receiving treatment at an ART clinic in Lilongwe found that 68% of 
patients’ last pregnancies were unintended (Haddad, 2011). The most recent study of the 
reproductive practices of urban Malawian women on ART found that fertility rates tend to 
increase as length of time on ART increases beyond 6 months (Tweya et al., 2013), a finding 
similar to those cited previously in the region (Kaida et al., 2008; Tai et al., 2007). However, 
data were collected prior to the initiation of Option B+ in Malawi, and the fertility desires of 
women may have changed following nationwide implementation of the new policy. In a 
recent study of postpartum Malawian women, HIV-infected women were more likely than 
their HIV-uninfected counterparts to desire no further children (O’Shea et al., 2015). ART 
status was not measured in this study, however, and the association between ART and 
fertility desire among HIV-infected women remains largely unknown in the Option B+ era.
Malawi’s high fertility rate and low overall contraceptive prevalence underscore the need to 
understand the fertility desires of HIV-infected women. Specifically, it is important to 
understand how women receiving ART in the Option B+ era feel about having subsequent 
pregnancies, to ensure that any gaps in family planning are identified and met. Therefore, the 
primary objective of this study was to describe the current pregnancy intentions and family 
planning practices of pregnant women who had initiated ART at least 6 months prior to their 
current pregnancy. The secondary objective of this study was to evaluate the association 
between time on ART and current pregnancy intention.
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We conducted a cross-sectional study of pregnant HIV-infected Malawian women who 
initiated ART prior to their current pregnancy. Recruitment took place at the antenatal clinic 
of Bwaila Hospital, a District Hospital in Lilongwe, Malawi with over 15,000 deliveries per 
year. Eligibility criteria included HIV-infected pregnant women, aged 18 to 45 years, who 
were on ART for at least 6 months prior to the current pregnancy. Women were recruited 
from March to July 2014.
 Sample Size and Study Population
We planned to enroll a convenience sample of 220 participants, based on the number of 
HIV-infected women on ART whom we estimated would be eligible for and interested in the 
study during the recruitment period at Bwaila. In 2013, there was an HIV prevalence of 
14.7% among pregnant women receiving care at Bwaila, and an estimated one-third of these 
women were on ART at the time they became pregnant. From January to June 2013, 6,735 
women received antenatal care at the facility. Therefore, we estimated that 55 pregnant HIV-
infected patients on ART per month could potentially be recruited for the study.
 Study Recruitment
All antenatal patients at Bwaila Hospital were screened for eligibility into the study. Eligible 
patients were taken to a private room and underwent the informed consent process in 
Chichewa with a Research Assistant fluent in both English and Chichewa. Those willing to 
provide informed consent were enrolled.
 Data Collection
Participants completed a face-to-face 30-minute survey, which collected information on 
demographics, HIV history, ART regimen history and reason for ART initiation, 
reproductive intentions, and family planning knowledge and preferences. ART history and 
date of last DMPA injection and subdermal implant insertion, if applicable, were verified 
using the patient’s health passport. Dates of method use for the injectable contraceptive, 
IUC, and implant were collected from the health passports to ascertain whether the 
pregnancy occurred within the period of efficacy of the method.
 Measures of Pregnancy Intention and Time on ART
A pregnancy was defined as ‘Intended’ if the participant had wished to become pregnant at 
the time of conception, ‘Mistimed’ if the participant had wished to become pregnant at a 
later time, and ‘Unwanted’ if she had not wished to become pregnant at any time. The 
primary exposure of interest, time on ART, was dichotomized into less than or greater than 
two years.
 Data Management and Statistical Analysis
Paper documents and consent forms were kept in study binders in a locked study office. All 
study data were double entered into a password-protected Microsoft Access study database, 
which was constructed with appropriate logic and validation checks to minimize data entry 
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error. The Access data were exported and analyzed using Stata version 13.0 (StataCorp, 
College Station, TX).
Descriptive statistics were calculated for categorical variables, and the Student’s t-test was 
used to compare continuous variables by pregnancy intention. Pearson’s chi-square tests and 
Fisher’s exact test were used to compare distributions of categorical variables by pregnancy 
intention. A two-sided p-value of 0.05 was considered statistically significant for all 
comparisons.
Modified Poisson regression with robust variance to estimate prevalence ratios was 
performed to evaluate the association between time on ART and the outcome of current 
pregnancy intention. In this analysis, we compared Mistimed versus Intended pregnancies 
and Unwanted versus Intended pregnancies. The fully adjusted model included variables that 
were possible confounders of time on ART and pregnancy intention, including age, number 
of living children, and first pregnancy with the woman’s current partner.
 Ethical considerations
Ethical approval for this study was obtained by both the University of North Carolina-
Chapel Hill Institutional Review Board and the Malawian National Health Sciences 
Research Committee.
 Results
A total of 480 patients were screened, of whom 237 were eligible. 220 (93%) eligible 
participants participated in the study. The most common reasons for ineligibility were lack 
of a complete health passport, being on ART for less than 6 months, and age under 18 years. 
17 eligible patients declined to participate. Most common reasons for nonparticipation were 
lack of time and desire for partner approval prior to study participation.
 Demographic characteristics and ART history
Most of the women surveyed (63%) were between the ages of 25 and 34 years, and nearly 
all (94%) were currently married (Table 1). A majority of women (74%) had been diagnosed 
with HIV at least 3 years ago. Half of women (48%) had initiated ART in the pre-Option B+ 
era, though most women (82%) had been on ART less than 5 years. Nearly all women (95%) 
were on the current Malawian first line combination of Tenofovir/Lamivudine/Efavirenz. 
Sixty-eight percent of women had initiated ART according to WHO clinical stage or CD4 
criteria, while 32% initiated ART while pregnant or breastfeeding.
 Current pregnancy intention
Seventy-five percent of surveyed women stated that their current pregnancy was either 
Mistimed (16%) or Unwanted (59%). Women who had been on ART for 2 years or more 
were more likely than those on ART for less than 2 years to have an Unwanted pregnancy 
(65% versus 45%) and less likely to have a Mistimed pregnancy (14% versus 20%) or 
Intended pregnancy (21% versus 35%; p=0.03)(Table 2). Women who were on ART for 2 
years or more were also more likely to have been married for at least 5 years (68% versus 
O’SHEA et al. Page 4













47%; p=0.005), less likely to report this was their first pregnancy with their partner (35% 
versus 53%; p=0.01), and less likely to have no living children (7% versus 26%; p<0.001). 
In multivariate analysis, there was no significant association between time on ART and 
having a Mistimed versus Intended pregnancy when adjusted for age, number of living 
children, and first pregnancy with the participant’s current partner (Adjusted PR 1.07; 95% 
CI: 0.60, 1.91)(Table 3). There was also no significant association between time on ART and 
having an Unwanted versus Intended pregnancy (Adjusted PR 1.08; 95% CI: 0.85, 1.37). In 
this model, the only predictor of having an Unwanted pregnancy was the number of living 
children (Adjusted PR for Unwanted versus Intended pregnancy: 1.18; 95% CI: 1.09, 1.28). 
Reason for ART initiation did not significantly change the beta coefficient in either of the 
pregnancy intention analyses, and was by itself not associated with pregnancy intention.
 Contraception used at conception
Seventy-nine percent of women reported using at least one contraceptive method during the 
time of conception (Table 2). Among these 173 women, the most common methods reported 
were condoms (91%), followed by injectables (9%), and the implant (9%). Dual method use 
was reported by 38 (22%) contraceptive users, of whom 11 were using oral contraceptives, 
11 were using injectables, 8 were using implants and 1 had undergone tubal sterilization. 
Seven other participants reported abstinence, natural family planning, breastfeeding or 
withdrawal in addition to condom use. Of the 15 women reporting injectable use, 3 had 
become pregnant during the contraceptive efficacy period of their last injection. Ten were 
overdue for their next injection at the time of conception, and 2 were unsure of last injection 
date. Of the 16 women reporting implant use at the time of conception, 2 had been using the 
3-year etonogestrel implant and 14 were using the 5-year levonorgestrel implant. All users 
of the levonorgestrel implant had the implant placed within the past 5 years of use and were 
thus still within its contraceptive efficacy period. Both women using the etonogestrel implant 
had the method placed within the past 3 years, within its contraceptive efficacy period. All 
16 implant users were using efavirenz-based ART at the time of conception.
 Future family planning preferences
When asked how many children they desired in the future, most women (75%) did not want 
any more children (Table 2). Nearly all women (99%) did not desire an additional pregnancy 
in two years. Most women (87%) stated that their partner had a positive attitude towards 
family planning. The most common methods women planned to use postpartum were 
condoms (88%), female sterilization (69%), and the implant (60%).
 Discussion
The majority of pregnant HIV-infected women on ART stated that their pregnancy was 
Unwanted (59%) or Mistimed (16%). In unadjusted analysis, women who were on ART 
longer appeared to be more likely to experience an Unwanted pregnancy. However, after 
adjustment, length of time on ART was not associated with current pregnancy intention 
because women on ART for longer periods of time generally had more living children. 
Number of living children, not time on ART, was the main determinant of pregnancy 
intention in our population. The high proportion of women who experienced an unintended 
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pregnancy underscores a need to ensure access to the most effective contraceptive methods 
as growing numbers of HIV-infected women continue to initiate lifelong ART in the Option 
B+ era.
ART use has previously been associated with increased pregnancy rates in sub-Saharan 
Africa when compared to HIV-infected women not using ART (Kaida et al., 2006; Makumbi 
et al., 2011; Myer et al., 2010), either due to improvements in health leading to higher 
probability of conception or increased hope following treatment initiation leading to 
increased fertility desire. Interestingly, the majority of our participants reported that their 
current pregnancy was unintended, suggesting that the former justification may have been 
more common in our study population. HIV status alone has not been shown to deter repeat 
pregnancy in studies from South Africa, Tanzania, Botswana, and Zimbabwe (Bussmann et 
al., 2007; Myer, Morroni, & Cooper, 2006; Myer, Morroni, & Rebe, 2007; Sedgh, Larsen, 
Spiegelman, Msamanga, & Fawzi, 2005; Smee, 2011). The relationship between length of 
time on ART and pregnancy intention has not been assessed in the Option B+ era. We found 
no association between length of time on ART and pregnancy intention among our study 
participants. This may be attributable to similar overall health status between those who had 
been on ART despite differing lengths of time on ART and reasons for ART initiation. As 
increasing numbers of women initiate ART under Option B+, they will also likely be in good 
health at the time of enrollment and without compromised immune status. Similarly, women 
on ART for longer time may enjoy improved health status from long-term treatment, leading 
to similar fertility desires between the two groups.
Most of our participants experienced an Unwanted, rather than a Mistimed pregnancy. In 
other words, they did not desire any more children. Attitudes toward reproduction among 
HIV-infected women are complex, given cultural norms promoting childbearing and social 
stigma surrounding HIV (Cooper et al., 2007). On one hand, HIV-related concerns have 
been described as deterrents to childbearing, stemming from poor health, fears of 
pregnancy’s negative effects on health, and anxiety of HIV transmission (Chen, Philips, 
Kanouse, Collins, & Miu, 2001; Cooper et al., 2007; da Silveira Rossi, Fonsechi-Carvasan, 
Makuch, Amaral, & Bahamondes, 2005; Kirshenbaum et al., 2004). Consistent with this 
trend, postpartum HIV-infected Malawian women at the same hospital were more likely than 
their HIV-uninfected counterparts to report unintended pregnancy and decreased future 
fertility desire (O’Shea et al., 2015), while knowledge of HIV-infected status also decreased 
fertility desire among nonpregnant Malawian women (Hoffman et al., 2008). However, those 
with fewer living children and positive subjective health reported increased fertility 
intentions, which is consistent with other studies in sub-Saharan Africa (Loko et al., 2005; 
Nebie et al., 2001). HIV infection is not the sole determinant of childbearing preferences, 
which may also be influenced by experiences with ART. A majority of patients at an ART 
care center in Ethiopia desired future pregnancy (Negash, Yusuf, & Tefera, 2013), while 
HIV-infected patients in South Africa reported that the positive health benefits of ART 
would make them reconsider reproductive options (Cooper et al., 2007). Our findings 
demonstrate that many HIV-infected women in Malawi desire to limit childbearing despite 
consistent access to ART and cultural norms promoting childbearing. However, we do not 
know whether our participants’ fertility desires are a result of stigma surrounding HIV 
status, perceived health status, or other compelling socioeconomic or cultural reasons. A 
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multitude of competing factors and life circumstances affect childbearing intentions and 
evolve throughout a woman’s reproductive years (Sennott & Yeatman, 2012). The growing 
availability of lifelong ART under the Option B+ policy will add another level of complexity 
to reproductive decision-making among HIV-infected women. Our findings underscore the 
need to ensure that HIV-infected women are provided the most effective contraceptive 
methods to meet their family planning needs and counseled appropriately throughout their 
reproductive years.
Understanding women’s contraceptive preferences while ensuring access to reliable methods 
of contraception is an important unmet need. The unintended pregnancies experienced by 
our population may have been the result of a combination of increased probability of 
conception due to improved immunological status, insufficient contraceptive coverage, and 
potentially decreased contraceptive efficacy due to ART. Most of our study participants 
reported using condoms as the method of contraception rather than more effective methods. 
We did not collect specific information regarding the consistency of condom use or personal 
control over condom use. Fewer women were using hormonal methods at the time of 
conception, which is consistent with their lower contraceptive failure rates. Dual method use 
with condoms and another family planning method was low, which is not unexpected, as 
women using two contraceptive methods are less likely to become pregnant. Given the high 
rates of unintended pregnancy experienced by our population and the low reported usage of 
effective, female-initiated contraception, it is essential to understand why many HIV-infected 
women who do not desire pregnancy are not using the most effective family planning 
methods to prevent pregnancy. HIV-infected women in the region have previously reported 
experiencing pregnancy while using contraception. One third of HIV-infected postpartum 
Malawian women reported using contraception before their most recent pregnancy, with the 
most popular methods being condoms, followed by injectables and oral contraceptives 
(O’Shea et al., 2015). Half of HIV-infected pregnant Zimbabwean women also reported 
using contraception prior to their current pregnancy (McCoy et al., 2014). These pregnancies 
may also be attributable to insufficient or inconsistent use of effective contraception, such as 
high rates of condom use and low dual method use. The majority of women using injectables 
in our study were overdue for their next injection when they became pregnant, indicating 
potential pregnancies due to inability to consistently access and use effective contraception.
Hormonal contraceptive failure among women on ART, such as those reported by our 
participants, have also been reported by HIV-infected South African women (Schwartz et al., 
2012). Among these women, 8.6% of unplanned pregnancies involved hormonal 
contraceptive failure, including two failures from combined oral contraceptives and seven 
from injectables. Two (1%) of our 173 study participants who were using contraception were 
using the etonogestrel implant, while 14 (8%) were using the levonorgestrel implant at the 
time they became pregnant. Reduced etonogestrel and levonorgestrel concentrations have 
been reported in users of the subdermal implant who were also on efavirenz-based ART 
(Scarsi et al., 2014; Vieira et al., 2014). Notably, the implant was the third most common 
method our study participants planned to use postpartum. Given the efavirenz-based regimen 
used under the Malawian Option B+ guidelines, the potential interaction raises concerns 
about reduced contraceptive efficacy in HIV-infected women who initiate ART and wish to 
use the implant to prevent pregnancy. Nonetheless, the contraceptive implant remains one of 
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the most effective methods available to HIV-infected women on ART wishing to prevent 
pregnancy and was still associated with lower pregnancy rates than short-acting 
contraceptive methods among women using efavirenz in a large study in Kenya (Patel et al., 
2015). Further studies are needed to counsel women on ART about the most effective 
methods of contraception available.
Despite Malawi’s success in scaling access to ART among pregnant women in recent years, 
many HIV-infected women on ART remain unable to fully achieve their family planning 
goals. Malawian family planning providers have previously cited understaffing, lack of 
trained providers in LARC insertions, and insufficient family planning commodities in 
clinics as barriers to access to family planning, in addition to community biases towards 
short-acting methods (manuscript under review). As greater numbers of Malawian women 
continue on lifelong ART, a shift in policy is urgently needed to prioritize the comparatively 
lagging family planning prong of the HIV management strategy by addressing these barriers, 
and improving the current integration of HIV and family planning care. Such efforts would 
require a focus on the integration of a wider range of evidence-based contraceptive methods, 
in addition to condoms and short-acting methods, as part of standard ART care. 
Simultaneous efforts are required to better understand why, in addition to barriers to family 
planning provision, Malawian HIV-infected women on ART are not using the most effective 
contraceptive methods available to meet their family planning goals, and how they make 
their contraceptive decisions.
We did not collect specific information regarding the current health status of our 
participants, which limits the generalizability of our results to the broader population of 
HIV-infected women on ART. Many participants who initiated ART in the Option B+ era 
reported initiating therapy for CD4 or WHO criteria. This may be because most women who 
initiated ART in the Option B+ era may have yet to experience another pregnancy. Given the 
negative impact of HIV disease progression on fertility and the fact that all women in our 
sample were able to achieve pregnancy (Ross et al., 2004), our study participants were likely 
healthier than the general population of HIV-infected women on ART. Nonetheless, with the 
continued implementation of Option B+ in Malawi, many HIV-infected women will 
continue to be at high risk of unintended pregnancy.
In conclusion, our population of HIV-infected Malawian women on ART experienced high 
rates of unintended pregnancy in the Option B+ era. Many of these pregnancies can be 
attributed to insufficient use of the most effective methods of contraception, including dual 
method use and effective long-acting contraception. As ART coverage is increased in 
Malawi, greater country-level priority must be placed on prevention of unintended 
pregnancy among HIV-infected women to achieve their family planning goals while 
preventing mother-to-child transmission of HIV. As Option B+ continues to be implemented 
in Malawi and increasing numbers of HIV-infected women initiate lifelong ART, ensuring 
that we understand their fertility intentions and contraceptive decision making process will 
allow us to design and promote effective strategies to help them to meet their family 
planning needs and reduce their high rates of unintended pregnancy.
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Table 3
Factors associated with having a Mistimed versus Intended pregnancya
Unadjusted PR (95% CI) Adjusted PR (95% CI)
Time on ART greater than 2 years 1.13 (0.66 1.94) 1.07 (0.60 1.91)
Age 1.02 (0.97 1.08) 1.0 (0.93 1.07)
Number of living children 1.21 (1.0 1.47) 1.26 (0.98 1.63)
First pregnancy with partner 0.98 (0.57 1.66) 1.13 (0.66 1.93)
PR=prevalence ratio, CI=confidence interval
a
Observations exclude inappropriate responses and nonresponses.
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Table 4
Factors associated with having an Unwanted versus Intended pregnancya
Unadjusted PR (95% CI) Adjusted PR (95% CI)
Time on ART greater than 2 years 1.34 (1.03 1.72) 1.08 (0.85 1.37)
Age 1.04 (1.02 1.06) 1.01 (0.99 1.04)
Number of living children 1.23 (1.15 1.32) 1.18 (1.09 1.28)
First pregnancy with partner 0.79 (0.63 0.98) 0.89 (0.72 1.08)
PR=prevalence ratio, CI=confidence interval
a
Observations exclude inappropriate responses and nonresponses.
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